Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Improving care to patients with ischemic heart disease: experiences in a single network of the Veterans Health Administration.

Pineros SL, Sales AE, Li YF, Sharp ND.

Worldviews Evid Based Nurs. 2004;1 Suppl 1:S33-40.

PMID:
17129333
2.
3.
4.

Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol.

Goldberg KC, Melnyk SD, Simel DL.

Am J Manag Care. 2007 Sep;13(9):530-4.

5.

Frequency of serum low-density lipoprotein cholesterol measurement and frequency of results < or=100 mg/dl among patients who had coronary events (Northwest VA Network Study).

Sloan KL, Sales AE, Willems JP, Every NR, Martin GV, Sun H, Pineros S, Sharp N.

Am J Cardiol. 2001 Nov 15;88(10):1143-6.

PMID:
11703960
7.

Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center.

Williams ML, Morris MT 2nd, Ahmad U, Yousseff M, Li W, Ertel N; VANJHCS research group. Veterans Affairs of New Jersey Healthcare System.

Ethn Dis. 2002 Winter;12(1):S1-58-62.

PMID:
11913623
8.

Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.

Coodley GO, Jorgensen M, Kirschenbaum J, Sparks C, Zeigler L, Albertson BD.

Am J Med. 2008 Jul;121(7):604-10. doi: 10.1016/j.amjmed.2008.02.031. Epub 2008 Jun 4.

PMID:
18538295
12.
13.

Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices.

Walsh MN, Simpson RJ Jr, Wan GJ, Weiss TW, Alexander CM, Markson LE, Berger ML, Pearson TA.

Am J Manag Care. 2002 Nov;8(11):937-46.

14.

Quality improvement initiatives improve hypertension care among veterans.

Choma NN, Huang RL, Dittus RS, Burnham KE, Roumie CL.

Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):392-8. doi: 10.1161/CIRCOUTCOMES.109.862714. Epub 2009 Jun 16.

15.

Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.

Maddox TM, Borden WB, Tang F, Virani SS, Oetgen WJ, Mullen JB, Chan PS, Casale PN, Douglas PS, Masoudi FA, Farmer SA, Rumsfeld JS.

J Am Coll Cardiol. 2014 Dec 2;64(21):2183-92. doi: 10.1016/j.jacc.2014.08.041. Epub 2014 Nov 19.

17.

Correlates of repeat lipid testing in patients with coronary heart disease.

Virani SS, Woodard LD, Wang D, Chitwood SS, Landrum CR, Urech TH, Pietz K, Chen GJ, Hertz B, Murawsky J, Ballantyne CM, Petersen LA.

JAMA Intern Med. 2013 Aug 12;173(15):1439-44. doi: 10.1001/jamainternmed.2013.8198.

PMID:
23817669
18.

Cost of lipid lowering in patients with coronary artery disease by case method learning.

Kiessling A, Zethraeus N, Henriksson P.

Int J Technol Assess Health Care. 2005 Spring;21(2):180-6.

PMID:
15921057
19.

Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial.

Nyman JA, Martinson MS, Nelson D, Nugent S, Collins D, Wittes J, Fye CL, Wilt TJ, Robins SJ, Bloomfield Rubins H; VA-HIT Study Group.

Arch Intern Med. 2002 Jan 28;162(2):177-82.

PMID:
11802751
20.

Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.

Harats D, Leibovitz E, Maislos M, Wolfovitz E, Chajek-Shaul T, Leitersdorf E, Gavish D, Gerber Y, Goldbourt U; HOLEM Study Group.

Isr Med Assoc J. 2005 Jun;7(6):355-9.

Supplemental Content

Support Center